Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH STRIDES PHARMA SCIENCE PANACEA BIOTECH/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x -60.9 -1,455.3 - View Chart
P/BV x 0.9 3.3 26.9% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 PANACEA BIOTECH   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
STRIDES PHARMA SCIENCE
Mar-23
PANACEA BIOTECH/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs191392 48.8%   
Low Rs107263 40.7%   
Sales per share (Unadj.) Rs75.1408.5 18.4%  
Earnings per share (Unadj.) Rs-5.5-25.6 21.5%  
Cash flow per share (Unadj.) Rs0.91.4 64.2%  
Dividends per share (Unadj.) Rs01.50 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs137.7242.8 56.7%  
Shares outstanding (eoy) m61.2590.30 67.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.00.8 247.6%   
Avg P/E ratio x-27.1-12.8 211.3%  
P/CF ratio (eoy) x170.0239.6 70.9%  
Price / Book Value ratio x1.11.4 80.3%  
Dividend payout %0-5.9 0.0%   
Avg Mkt Cap Rs m9,14229,603 30.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2657,320 17.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,59936,884 12.5%  
Other income Rs m5171,352 38.2%   
Total revenues Rs m5,11638,236 13.4%   
Gross profit Rs m47830 5.7%  
Depreciation Rs m3912,433 16.1%   
Interest Rs m442,611 1.7%   
Profit before tax Rs m128-2,862 -4.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m466-553 -84.2%   
Profit after tax Rs m-337-2,309 14.6%  
Gross profit margin %1.02.2 45.4%  
Effective tax rate %363.519.3 1,881.4%   
Net profit margin %-7.3-6.3 117.2%  
BALANCE SHEET DATA
Current assets Rs m5,62331,353 17.9%   
Current liabilities Rs m3,29729,902 11.0%   
Net working cap to sales %50.63.9 1,285.9%  
Current ratio x1.71.0 162.6%  
Inventory Days Days5971 82.5%  
Debtors Days Days48129 37.1%  
Net fixed assets Rs m7,02831,300 22.5%   
Share capital Rs m61903 6.8%   
"Free" reserves Rs m8,37521,025 39.8%   
Net worth Rs m8,43621,928 38.5%   
Long term debt Rs m20211,398 1.8%   
Total assets Rs m12,71263,734 19.9%  
Interest coverage x3.9-0.1 -4,049.8%   
Debt to equity ratio x00.5 4.6%  
Sales to assets ratio x0.40.6 62.5%   
Return on assets %-2.30.5 -485.9%  
Return on equity %-4.0-10.5 38.0%  
Return on capital %2.0-0.8 -265.5%  
Exports to sales %43.346.7 92.8%   
Imports to sales %24.40-   
Exports (fob) Rs m1,99217,213 11.6%   
Imports (cif) Rs m1,124NA-   
Fx inflow Rs m1,99218,113 11.0%   
Fx outflow Rs m1,191672 177.3%   
Net fx Rs m80117,442 4.6%   
CASH FLOW
From Operations Rs m-4,225444 -951.2%  
From Investments Rs m4,3033,025 142.3%  
From Financial Activity Rs m-184-2,139 8.6%  
Net Cashflow Rs m-1051,328 -7.9%  

Share Holding

Indian Promoters % 73.6 27.4 268.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 38.9 2.4%  
FIIs % 0.3 19.5 1.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.4 72.6 36.4%  
Shareholders   47,091 91,182 51.6%  
Pledged promoter(s) holding % 0.0 69.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Panacea Biotech vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Panacea Biotech vs STRIDES PHARMA SCIENCE Share Price Performance

Period Panacea Biotech STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day -1.74% 1.16% 1.18%
1-Month -20.01% 0.35% -0.75%
1-Year 11.75% 176.88% 61.82%
3-Year CAGR -12.26% -3.35% 18.16%
5-Year CAGR -9.98% 10.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the Panacea Biotech share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of Panacea Biotech hold a 73.6% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 27.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Panacea Biotech and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, Panacea Biotech paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

STRIDES PHARMA SCIENCE paid Rs 1.5, and its dividend payout ratio stood at -5.9%.

You may visit here to review the dividend history of Panacea Biotech, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.